# An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin

> **NCT00776659** · — · TERMINATED · sponsor: **Pfizer** · enrollment: 39 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **OTHER:** Aromasin

## Key facts

- **NCT ID:** NCT00776659
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776659, "An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00776659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*